Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NAActive, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Liver Cancer
Interventions
DEVICE

Kilovoltage Intrafraction Monitoring

KIM is a novel intrafraction real-time tumour localization method. It involves a single gantry-mounted kV x-ray imager acquiring 2D projections of implanted fiducial markers. 3D positions are then reconstructed by maximum likelihood estimation of a 3D probability density function.

Trial Locations (4)

2049

Westmead Hospital, Westmead

2750

Nepean Hospital, Penrith

3000

Peter MacCallum Cancer Centre, Melbourne

4102

Princess Alexandra Hospital, Woolloongabba

All Listed Sponsors
lead

University of Sydney

OTHER